Skip to content



Financing is the rocket fuel of today’s global economy, enabling startups to get off the ground, giving existing businesses the chance to grow and scale their operations, and helping market leaders be nimble and meet the growing needs of their clients, customers or constituencies.

At Loeb, we advise banks, investment funds and other financial institutions in financing transactions of every size and type, from senior secured debt facilities, convertible debt, leveraged acquisitions and asset-based lending to private investment in PIPE transactions, margin loans, life insurance premium financings, and cross-border and multicurrency loans. We also regularly represent borrowers in these same transactions.

Our team handles every stage of financing, from the structuring of proposals through negotiation, documentation and closing, as well as the administration of credit facilities and the issuance of debt securities. Loeb lawyers provide clients in the United States and across the globe with in-depth market knowledge, practical and innovative solutions, and effective representation to get their deals done and to meet their goals.

  • Our courtroom-tested litigators assert and defend patent claims in federal courts throughout the United States. We’ve served as lead trial counsel in more than 100 patent, trade secret and other technology-related litigation, including defending against infringement actions brought by nonpracticing entities in the Eastern District of Texas and other plaintiff-friendly jurisdictions, and in litigation between competitors seeking to obtain or challenge an exclusive position in the market. We’ve also argued appeals before the United States Court of Appeals for the Federal Circuit.
  • We counsel clients on the effective use of Patent Trial and Appeal Board proceedings to protect their IP rights and as a key strategy for defending against parallel patent litigation in federal court. Our patent litigators are equally skilled in using PTAB proceedings — including inter partes reviews (IPR), postgrant reviews, covered business method (CBM) reviews and ex-parte re-examinations — to defend against patent challenges brought by competitors, to secure confirmation of our clients’ patent claims, and to invalidate competitor and third-party patents.
  • Our team's strong litigation and claims-dispute background allows us to anticipate and mitigate IP risks and provide strategic patent prosecution that maximizes protection and value for our clients' innovations and technologies. We partner with innovators at every stage of the patent process, from determining patentability and conducting patent searches through preparing and filing U.S. and foreign patent applications crafted to secure the strongest protection worldwide.

    Clients seek our advice on "freedom to operate" opinions as well as opinions on patent infringement, invalidity and enforceability. Loeb partners with several artificial intelligence firms to create analyses and visualizations of a patent area to help clients identify areas to expand and exploit, and those to avoid. We work with clients to establish in-house patent programs and policies and strategize with across industries and market sectors to help them build and take full competitive advantage of their patent portfolios.
  • Loeb’s patent lawyers work with major branded drug companies, biotechnology firms and medical device manufacturers in order to obtain, protect and monetize the companies’ IP assets, achieve their business objectives and protect their products against market inroads by generics. We handle all phases of Paragraph IV disputes under the Hatch-Waxman Act, including litigating the infringement, validity and enforceability of patents. Our team also provides a range of services that include pre-litigation strategy and counsel, IPR and other postgrant proceedings, due diligence in connection with corporate and commercial transactions, and sophisticated advice on FDA exclusivity policies and FTC oversight of settlements and orphan drug rules.
  • Loeb has a deep bench of professionals across the United States and China focused on helping science-based companies take full competitive advantage of patent portfolios through corporate partnering, licensing, mergers and acquisitions, and other commercial transactions. We have partnered with pharmaceutical specialists, business consultants, researchers and in-house counsel to facilitate hundreds of transactions across various technologies and at all stages of product development. Our team is well-versed in the business, regulatory and commercial issues inherent in these transactions — from both the buy- and sell-side perspectives — with the ability to call on a team of IP, regulatory, reimbursement, tax, antitrust and other lawyers and professionals as needed.

Key Contact